Fate Therapeutics, Inc. (FATE)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 5.73 |
| Open | 5.80 |
| Bid | 5.96 x 1000 |
| Ask | 5.96 x 1800 |
| Day's range | 5.79 - 6.32 |
| 52-week range | 4.02 - 43.12 |
| Volume | |
| Avg. volume | 3,379,520 |
| Market cap | 579.136M |
| Beta (5Y monthly) | 1.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.44 |
| Earnings date | 27 Feb 2023 - 03 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.77 |
- Simply Wall St.
Calculating The Fair Value Of Fate Therapeutics, Inc. (NASDAQ:FATE)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Fate Therapeutics...
- Zacks
Down -52.57% in 4 Weeks, Here's Why Fate Therapeutics (FATE) Looks Ripe for a Turnaround
Fate Therapeutics (FATE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- Zacks
FATE To End Janssen Deal and Prioritize Pipeline Development
FATE decides not to continue its collaboration and option agreement with Janssen. The company also conducts a strategic review.
© 2023 Yahoo. All rights reserved.
